AtriCure (ATRC) Guidance Reset Should Be Positive Clearing Event - Piper Jaffray

August 5, 2016 8:27 AM EDT
Get Alerts ATRC Hot Sheet
Price: $15.54 -3.72%

Rating Summary:
    10 Buy, 0 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 35 | Down: 31 | New: 11
Trade ATRC Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Piper Jaffray analyst Brooks West cut his price target on AtriCure Inc. (NASDAQ: ATRC) to $17.00 (from $22.00) following Q2 results, but maintained an Overweight rating saying guidance reset could be a positive clearing event.

West commented, "AtriCure reported 2Q16 revenues of $39.7M (+21.5% cc) vs. consensus of $39.8M and lowered FY16 revenue guidance from 25% to 20-22%. Management also backed off its long-term 18% growth bogey stating that while it was achievable it was comfortable with estimates in the “mid-teens” range. This removes one of the biggest concerns we hear from investors who want to own ATRC– both because the stock is significantly undervalued vs. peers with similar growth outlooks and for the potential acceleration in revenues in the 2019/2020 timeframe on a ramp in MIS procedures post the CONVERGE trial (making the company less reliant on concomitant open chest procedures). Management also announced that it had received FDA approval to double CONVERGE sites which we believe will accelerate enrollment and pull-forward approval timelines. We are lowering our forward estimates and encourage investors to take advantage of weakness to start positions. PT to $17 from $22."

For an analyst ratings summary and ratings history on AtriCure Inc. click here. For more ratings news on AtriCure Inc. click here.

Shares of AtriCure Inc. closed at $14.82 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Piper Jaffray, Brooks West

Add Your Comment